Bias Capital
Overview
Bias Capital is a venture capital firm and angel syndicate based in San Francisco that focuses on early-stage and seed-stage investments. The firm invests across multiple sectors, including healthcare technology, B2C Non-Financial Services, Specialized Finance, and Business/Productivity Software. In July 2023, the firm led a $25 million Series A round for Parker Health, but later canceled the investment in February 2025, citing concerns of potential fraud and misleading financial disclosures found during due diligence. A principal at the firm is Maximillian Naza, who was slated to join the Parker Health board. Other investments include Grabango, Wayflyer, and Fintor.
Portfolio Companies
2
Website
bias.capitalInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Blue Social | Apr 2020 | Seed | - |
| Parker Health | Jul 2023 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bias Capital based?
Bias Capital is headquartered in San Francisco, California, United States.
When was Bias Capital founded?
Founding year information for Bias Capital is not publicly available.
How many portfolio companies does Bias Capital have?
Bias Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Bias Capital's portfolio?
Portfolio companies visible on Caplight include Blue Social, Parker Health.
What was Bias Capital's most recent investment shown here?
Bias Capital's most recent investment in this portfolio sample was in Parker Health in 2023.
What sectors does Bias Capital focus on?
Bias Capital focuses on Healthcare & Life Sciences, Consumer & Commerce, Crypto & Web3, Enterprise Software.
What company stages does Bias Capital focus on?
Bias Capital typically invests at the Early stage.